(WT) - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US97717P1049
Stock: ETFs, Index Licensing, 401(k) Platform, Advisory
Total Rating 68
Risk 94
Buy Signal 0.41
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.11% |
| Yield on Cost 5y | 2.81% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 84.5% |
| Payout Ratio | 16.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.5% |
| Relative Tail Risk | -4.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.52 |
| Alpha | 44.40 |
| Character TTM | |
|---|---|
| Beta | 1.164 |
| Beta Downside | 1.235 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.13% |
| CAGR/Max DD | 1.07 |
Description: WT January 14, 2026
WisdomTree, Inc. (NYSE:WT) is an ETF sponsor and asset manager that offers exchange-traded funds across equities, currencies, fixed income, and alternative asset classes, while also licensing its fundamentally weighted indexes to third-party product providers and supporting the inclusion of its ETFs in 401(k) plans.
As of FY 2023, WisdomTree reported approximately $110 billion in assets under management (AUM), a 15% year-over-year revenue increase driven largely by higher inflows into its fixed-income and “smart beta” equity products; however, fee compression in the broader ETF market and a rising interest-rate environment remain material risks to future growth. The firm’s core differentiator-fundamentally weighted indexing-has gained traction as investors seek alternatives to market-cap weighting, especially in a period where macro-economic uncertainty is prompting a shift toward income-focused and lower-volatility strategies.
For a deeper quantitative breakdown of WisdomTree’s valuation metrics, see the ValueRay profile.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 96.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -2.21 > 1.0 |
| NWC/Revenue: 101.1% < 20% (prev 49.20%; Δ 51.88% < -1%) |
| CFO/TA 0.09 > 3% & CFO 127.8m > Net Income 96.4m |
| Net Debt (400.4m) to EBITDA (147.0m): 2.72 < 3 |
| Current Ratio: 2.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (146.4m) vs 12m ago 1.69% < -2% |
| Gross Margin: 65.39% > 18% (prev 0.74%; Δ 6466 % > 0.5%) |
| Asset Turnover: 37.06% > 50% (prev 40.01%; Δ -2.95% > 0%) |
| Interest Coverage Ratio: 5.75 > 6 (EBITDA TTM 147.0m / Interest Expense TTM 25.0m) |
Altman Z'' 3.48
| A: 0.32 (Total Current Assets 716.4m - Total Current Liabilities 254.4m) / Total Assets 1.45b |
| B: 0.13 (Retained Earnings 185.0m / Total Assets 1.45b) |
| C: 0.12 (EBIT TTM 143.8m / Avg Total Assets 1.23b) |
| D: 0.18 (Book Value of Equity 189.1m / Total Liabilities 1.07b) |
| Altman-Z'' Score: 3.48 = A |
Beneish M -3.08
| DSRI: 0.92 (Receivables 46.6m/45.2m, Revenue 457.0m/407.9m) |
| GMI: 1.13 (GM 65.39% / 73.72%) |
| AQI: 0.72 (AQ_t 0.50 / AQ_t-1 0.70) |
| SGI: 1.12 (Revenue 457.0m / 407.9m) |
| TATA: -0.02 (NI 96.4m - CFO 127.8m) / TA 1.45b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of WT shares?
As of February 08, 2026, the stock is trading at USD 15.74 with a total of 3,489,690 shares traded.
Over the past week, the price has changed by -2.84%, over one month by +15.23%, over three months by +34.99% and over the past year by +64.46%.
Over the past week, the price has changed by -2.84%, over one month by +15.23%, over three months by +34.99% and over the past year by +64.46%.
Is WT a buy, sell or hold?
has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy WT.
- StrongBuy: 3
- Buy: 0
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the WT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.5 | 4.8% |
| Analysts Target Price | 16.5 | 4.8% |
| ValueRay Target Price | 21.6 | 37.3% |
WT Fundamental Data Overview January 31, 2026
P/E Trailing = 25.8438
P/E Forward = 19.0476
P/S = 5.324
P/B = 6.391
Revenue TTM = 457.0m USD
EBIT TTM = 143.8m USD
EBITDA TTM = 147.0m USD
Long Term Debt = 805.1m USD (from longTermDebt, last quarter)
Short Term Debt = 150.6m USD (from shortTermDebt, last quarter)
Debt = 956.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 400.4m USD (from netDebt column, last quarter)
Enterprise Value = 2.83b USD (2.43b + Debt 956.2m - CCE 555.9m)
Interest Coverage Ratio = 5.75 (Ebit TTM 143.8m / Interest Expense TTM 25.0m)
EV/FCF = 22.29x (Enterprise Value 2.83b / FCF TTM 127.1m)
FCF Yield = 4.49% (FCF TTM 127.1m / Enterprise Value 2.83b)
FCF Margin = 27.81% (FCF TTM 127.1m / Revenue TTM 457.0m)
Net Margin = 21.10% (Net Income TTM 96.4m / Revenue TTM 457.0m)
Gross Margin = 65.39% ((Revenue TTM 457.0m - Cost of Revenue TTM 158.2m) / Revenue TTM)
Gross Margin QoQ = 55.31% (prev 70.85%)
Tobins Q-Ratio = 1.96 (Enterprise Value 2.83b / Total Assets 1.45b)
Interest Expense / Debt = 0.89% (Interest Expense 8.47m / Debt 956.2m)
Taxrate = 33.26% (9.82m / 29.5m)
NOPAT = 96.0m (EBIT 143.8m * (1 - 33.26%))
Current Ratio = 2.82 (Total Current Assets 716.4m / Total Current Liabilities 254.4m)
Debt / Equity = 2.56 (Debt 956.2m / totalStockholderEquity, last quarter 373.4m)
Debt / EBITDA = 2.72 (Net Debt 400.4m / EBITDA 147.0m)
Debt / FCF = 3.15 (Net Debt 400.4m / FCF TTM 127.1m)
Total Stockholder Equity = 408.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.82% (Net Income 96.4m / Total Assets 1.45b)
RoE = 23.60% (Net Income TTM 96.4m / Total Stockholder Equity 408.5m)
RoCE = 11.85% (EBIT 143.8m / Capital Employed (Equity 408.5m + L.T.Debt 805.1m))
RoIC = 9.30% (NOPAT 96.0m / Invested Capital 1.03b)
WACC = 7.49% (E(2.43b)/V(3.39b) * Re(10.20%) + D(956.2m)/V(3.39b) * Rd(0.89%) * (1-Tc(0.33)))
Discount Rate = 10.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.67%
[DCF Debug] Terminal Value 82.94% ; FCFF base≈121.1m ; Y1≈149.4m ; Y5≈254.4m
Fair Price DCF = 31.22 (EV 4.79b - Net Debt 400.4m = Equity 4.39b / Shares 140.7m; r=7.49% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 81.70 | EPS CAGR: 24.87% | SUE: 2.18 | # QB: 1
Revenue Correlation: 94.22 | Revenue CAGR: 13.10% | SUE: 1.53 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.22 | Chg30d=+0.007 | Revisions Net=+2 | Analysts=6
EPS next Year (2026-12-31): EPS=0.96 | Chg30d=+0.032 | Revisions Net=+3 | Growth EPS=+20.7% | Growth Revenue=+22.9%
P/E Forward = 19.0476
P/S = 5.324
P/B = 6.391
Revenue TTM = 457.0m USD
EBIT TTM = 143.8m USD
EBITDA TTM = 147.0m USD
Long Term Debt = 805.1m USD (from longTermDebt, last quarter)
Short Term Debt = 150.6m USD (from shortTermDebt, last quarter)
Debt = 956.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 400.4m USD (from netDebt column, last quarter)
Enterprise Value = 2.83b USD (2.43b + Debt 956.2m - CCE 555.9m)
Interest Coverage Ratio = 5.75 (Ebit TTM 143.8m / Interest Expense TTM 25.0m)
EV/FCF = 22.29x (Enterprise Value 2.83b / FCF TTM 127.1m)
FCF Yield = 4.49% (FCF TTM 127.1m / Enterprise Value 2.83b)
FCF Margin = 27.81% (FCF TTM 127.1m / Revenue TTM 457.0m)
Net Margin = 21.10% (Net Income TTM 96.4m / Revenue TTM 457.0m)
Gross Margin = 65.39% ((Revenue TTM 457.0m - Cost of Revenue TTM 158.2m) / Revenue TTM)
Gross Margin QoQ = 55.31% (prev 70.85%)
Tobins Q-Ratio = 1.96 (Enterprise Value 2.83b / Total Assets 1.45b)
Interest Expense / Debt = 0.89% (Interest Expense 8.47m / Debt 956.2m)
Taxrate = 33.26% (9.82m / 29.5m)
NOPAT = 96.0m (EBIT 143.8m * (1 - 33.26%))
Current Ratio = 2.82 (Total Current Assets 716.4m / Total Current Liabilities 254.4m)
Debt / Equity = 2.56 (Debt 956.2m / totalStockholderEquity, last quarter 373.4m)
Debt / EBITDA = 2.72 (Net Debt 400.4m / EBITDA 147.0m)
Debt / FCF = 3.15 (Net Debt 400.4m / FCF TTM 127.1m)
Total Stockholder Equity = 408.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.82% (Net Income 96.4m / Total Assets 1.45b)
RoE = 23.60% (Net Income TTM 96.4m / Total Stockholder Equity 408.5m)
RoCE = 11.85% (EBIT 143.8m / Capital Employed (Equity 408.5m + L.T.Debt 805.1m))
RoIC = 9.30% (NOPAT 96.0m / Invested Capital 1.03b)
WACC = 7.49% (E(2.43b)/V(3.39b) * Re(10.20%) + D(956.2m)/V(3.39b) * Rd(0.89%) * (1-Tc(0.33)))
Discount Rate = 10.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.67%
[DCF Debug] Terminal Value 82.94% ; FCFF base≈121.1m ; Y1≈149.4m ; Y5≈254.4m
Fair Price DCF = 31.22 (EV 4.79b - Net Debt 400.4m = Equity 4.39b / Shares 140.7m; r=7.49% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 81.70 | EPS CAGR: 24.87% | SUE: 2.18 | # QB: 1
Revenue Correlation: 94.22 | Revenue CAGR: 13.10% | SUE: 1.53 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.22 | Chg30d=+0.007 | Revisions Net=+2 | Analysts=6
EPS next Year (2026-12-31): EPS=0.96 | Chg30d=+0.032 | Revisions Net=+3 | Growth EPS=+20.7% | Growth Revenue=+22.9%